Explore 3 Stock Ideas & Industry Insights Download Free Report

News

GEN Restaurant Group (NASDAQ:GENK) Trading Near All-Time Low: Second Quarter Loss and Working Capital in Focus

GEN is an Asian casual dining restaurant concept offering an extensive menu of traditional Korean and Korean-American food, including meats, poultry and seafood, founded in 2011.

Nitish Kishor | 06 November 2026

Georgia Banking Company (NASDAQ:GBC) Trading Near All-Time Low: Third Quarter Earnings and Tandem Merger in Focus

The quarter was the first full quarter of combined operations with Tandem Bancorp, Inc., whoseAcquisitionclosed on June 1, 2026. The company notes that sequential and year over year comparisons are affected by the merger.

Nitish Kishor | 06 November 2026

GeoVax Labs (NASDAQ:GOVX) Trading Near All-Time Low: Shares Down 5%, Second Quarter Loss and Going Concern Language in Focus

Total operating expenses were USD 4,442,072 against USD 6,271,188, and the loss from operations was USD 4,442,072 against USD 5,418,906. The net loss was USD 4,426,578 against USD 5,369,783, and the loss per share was USD 0.97 against USD 8.74 after retroactive adjustment for …

Nitish Kishor | 06 November 2026

Gloo (NASDAQ:GLOO) Trading Near All-Time Low: Fiscal Second Quarter Revenue Growth and Net Loss in Focus

Gloo says its mission is to build the leading technology platform and AI infrastructure for the faith and flourishing ecosystem, which it describes as among the oldest, largest and most resilient in the world.

Nitish Kishor | 06 November 2026

Granite Point Mortgage Trust (NYSE:GPMT) Trading Near All-Time Low: Shares Down 9%, Third Quarter Loss and Strategic Review in Focus

On September 23, 2026, the company announced that its board had initiated a process to review alternatives to enhance stockholder value, and it said the board is evaluating the full range of alternatives. On the call, management said it does not intend to answer …

Nitish Kishor | 06 November 2026

GT Biopharma (NASDAQ:GTBP) Trading Near All-Time Low: Shares Down 7%, Second Quarter Loss and Cash Position in Focus

GT Biopharma is focused on the development and commercialization of novel immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Dual Targeting TriKE fusion protein immune cell engager platforms.

Nitish Kishor | 06 November 2026

HCW Biologics (NASDAQ:HCWB) Trading Near All-Time Low: Second Quarter Loss and Nasdaq Compliance in Focus

HCW Biologics is a clinical stage biopharmaceutical company developing fusion immunotherapeutics to treat diseases promoted by chronic inflammation, including autoimmune disorders.

Nitish Kishor | 06 November 2026

HMH Holding (NASDAQ:HMH) Trading Near All-Time Low: Shares Down 4%, Third Quarter Revenue and Earnings in Focus

HMH describes itself as a leading provider of highly engineered, mission critical equipment solutions, with a portfolio of drilling equipment, services and systems used in offshore and onshore oil and gas drilling.

Nitish Kishor | 06 November 2026

Honeywell Aerospace (NASDAQ:HONA) Trading Near All-Time Low: Third Quarter Sales and Spin-Off Balance Sheet in Focus

The company describes itself as a leading global tier-1 aerospace and defense supplier, organized into the Electronic Solutions, Engines and Power Systems, and Control Systems segments serving Commercial Air Transport,BusinessAviation, and Defense and Space end markets.

Nitish Kishor | 06 November 2026

Horizon Technology Finance (NASDAQ:HRZN) Trading Near All-Time Low: Third Quarter NAV and Net Investment Income in Focus

Horizon lends to and invests in development stage companies in the technology, life science, healthcare information and services, and sustainability industries.

Nitish Kishor | 06 November 2026
Support

Hi! How can we help you today?

Loading…